http://www.law360.com/ Latest articles for organization: Abbott Laboratories Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/132915 The U.S. Department of Justice is investigating the way Abbott Laboratories has sold and marketed the anti-seizure drug Depakote, the company said Friday. http://www.law360.com/articles/132915 http://www.law360.com/articles/132584 A federal judge has upheld a jury verdict awarding Johnson & Johnson subsidiary Centocor Ortho Biotech Inc. and New York University a record $1.67 billion for their claims that Abbott Laboratories' flagship arthritis drug Humira infringed their patent. http://www.law360.com/articles/132584 http://www.law360.com/articles/132314 Kaiser Foundation Health Plan Inc. is appealing a judgment in favor of Abbott Laboratories in a patent and antitrust dispute involving multidistrict litigation over the hypertension drug Hytrin. http://www.law360.com/articles/132314 http://www.law360.com/articles/131390 Abbott Laboratories has launched another suit seeking to block a generic version of its cholesterol drug TriCor, this one targeting generics maker Impax Laboratories Inc. http://www.law360.com/articles/131390 http://www.law360.com/articles/131010 A British charitable trust has slapped Amgen Inc. and Pfizer Inc. subsidiary Wyeth with a lawsuit over the lucrative rheumatoid arthritis drug Enbrel, accusing the two defendants — which co-market Enbrel in the U.S. — of willfully infringing a single patent and ignoring demands for royalty payments. http://www.law360.com/articles/131010 http://www.law360.com/articles/130360 Wyeth Inc. and Cordis Corp. have asked a judge to dismiss or transfer a declaratory judgment suit filed by Boston Scientific Corp. in a fight over a patent related to drug coatings in stents, saying a suit they filed earlier elsewhere should take precedence. http://www.law360.com/articles/130360 http://www.law360.com/articles/129163 The U.S. Food and Drug Administration is investigating fire safety issues concerning certain types of power cords used in medical devices manufactured by Abbott Nutrition and Hospira Inc. http://www.law360.com/articles/129163 http://www.law360.com/articles/128638 A federal judge has refused to dismiss a putative class action accusing Ovation Pharmaceuticals Inc. and Lundbeck Inc. of jacking up the prices for pharmaceutical treatments of a certain congenital heart defect suffered most frequently by premature infants. http://www.law360.com/articles/128638 http://www.law360.com/articles/127278 The U.S. government has asked a federal judge throw out Abbott Laboratories Inc.’s deposition notices for government employees in the multidistrict litigation over allegedly inflated pharmaceutical wholesale prices. http://www.law360.com/articles/127278 http://www.law360.com/articles/126727 European Commission officials raided several major drug manufacturers on Tuesday, reportedly including Sanofi-Aventis SA, as part of an investigation into anti-competitive practices. http://www.law360.com/articles/126727 http://www.law360.com/articles/125139 Following a recent rash of mergers, the top European Union competition official on Tuesday said pharmaceutical companies should “look out” for investigations in the coming months. http://www.law360.com/articles/125139 http://www.law360.com/articles/124759 Abbott Laboratories plans to buy the pharmaceutical business of Belgium's Solvay Group for $6.6 billion in cash in a move to expand its presence in key emerging markets and diversify its drug portfolio. http://www.law360.com/articles/124759 http://www.law360.com/articles/124459 Having vacated a prior final judgment ruling due to a procedural error, a federal judge has again dismissed medical device maker MarcTec LLC's infringement suit against Johnson & Johnson subsidiary Cordis Corp. over stents. http://www.law360.com/articles/124459 http://www.law360.com/articles/124399 Pummeled with a $38 million verdict for infringing Church & Dwight Co. Inc.’s patents covering pregnancy test kits, Abbott Laboratories has agreed to pay $27 million in a settlement that ends the verdict appeal as well as an infringement countersuit. http://www.law360.com/articles/124399 http://www.law360.com/articles/124172 Less than a week after asking a court to dismiss Bristol-Myers Squibb Co. from a suit, the state of Arizona has revealed that the parties have reached a $900,000 settlement that will put to rest allegations that the pharmaceutical giant schemed to artificially boost average wholesale drug prices. http://www.law360.com/articles/124172 http://www.law360.com/articles/123945 Medical device manufacturers Wyeth and Cordis Corp. claim in a federal court suit filed Tuesday that stents made and sold by Boston Scientific Corp. and Abbott Laboratories infringe the companies' new patent relating to drug coatings in stents. http://www.law360.com/articles/123945 http://www.law360.com/articles/123465 Subsidiaries of London-based AstraZeneca PLC have been dismissed from several suits alleging Stryker Corp.’s anesthetic delivery system and several companies’ injectable painkillers caused thousands of patients to suffer cartilage damage. http://www.law360.com/articles/123465 http://www.law360.com/articles/123497 A class of indirect purchasers has requested final approval of a proposed allocation plan for a $65.7 million settlement of a consolidated action accusing Abbott Laboratories and Fournier Industrie et Sante of blocking generic competition for the cholesterol drug TriCor. http://www.law360.com/articles/123497 http://www.law360.com/articles/122825 The state of Arizona has asked a court to dismiss Bristol-Myers Squibb Co. from multidistrict litigation accusing a number of pharmaceutical companies of scheming to artificially boost average wholesale drug prices, following a settlement agreement between the two parties. http://www.law360.com/articles/122825 http://www.law360.com/articles/121652 Abbott Laboratories has asked a judge to throw out four recently amended complaints filed by pharmacies, wholesale direct drug purchasers and rival drug manufacturers alleging Abbott illegally jacked up the prices of its market-dominating HIV drugs, calling the complaints “a vain attempt to plead around” recent antitrust case law. http://www.law360.com/articles/121652